Skip to main content

Tag: Germany

Global Cannabis (THC+, THC-) How Did We Get Here Panel Berlin 2023 ICBC

Global Cannabis (THC+, THC-): How Did We Get Here?

Written by Johnny Green on . Posted in Business.

As the global cannabis industry continues to emerge, there were some recent hiccups in the road internationally with valuations falling in North America and other challenges abroad. The discussion in the video below, which was held at the 2023 International Cannabis Business Conference in Berlin, addresses some of the ups and downs we’ve seen in the cannabis markets around the world, including markets for THC+ and THC- products. Panelists include:

    • David Traylor – Senior Managing Director, Golden Eagle Partners
    • Rob McEvoy – Consultant & Public Speaker to the Cannabis Space
    • Jamie Pearson – International Consultant, New Holland Group
    • Robert T. Hoban – Member, Co-Chair of the Cannabis Industry Group, & Member-in-Charge of the Clark Hill Denver Office

We look forward to seeing you at Berlin 2024, as well as at our upcoming science and technology event in Slovenia this September!

germany-flag

Germany Releases More Cannabis Legalization Details

Written by Johnny Green on . Posted in Policy.

Germany’s long-awaited cannabis legalization measure is expected to be formally submitted to the cabinet next month, however, new details about the current version of the adult-use legalization measure were recently unveiled, providing further insight into what cannabis policy observers inside and outside of Germany can expect from the European nation’s cannabis policy modernization efforts.

For roughly the last two months an adult-use legalization measure has worked its way through the administrative review process in Germany, and many high-level details were released to the public via a press conference led by German Health Karl Lauterbach back in April.

The public learned in April that there would be a legal age set at 18 years old, that there would be a possession limit of 25 grams, and there would be a cultivation limit of 3 plants. Additionally, noncommercial cannabis clubs would be permitted as part of the proposal, and eventually, regional adult-use cannabis commerce pilot programs would be launched.

The new proposal seems to have evolved a bit, as recapped in a Twitter thread by VOC Nederland:

Noncommercial cannabis clubs cannot be located within 200 meters of a school, and the number of clubs will be capped at one club for every 6,000 residents according to the recently unveiled proposal.

Cannabis club permits will be valid for up to seven years, and members will be required to remain with the club they join for at least two months before they move their membership to a different club (members can only join one club at a time).

Provisions relating to regional adult-use cannabis commerce pilot programs, which will serve as the ‘second phase’ of German legalization, are expected to be released ‘in the second half of 2023.’

luxembourg flag

How Does Luxembourg’s Cannabis Law Compare To Germany’s Proposal?

Written by Johnny Green on . Posted in Policy.

Last week, Luxembourg’s Parliament approved a measure that legalizes cannabis possession and cultivation for adults. Unlike previous countries that have passed legalization measures (Uruguay, Canada, and Malta), Luxembourg’s legalization model does not include a commercial component, at least not initially.

Instead, what lawmakers passed by a 38-22 vote a handful of days ago removed criminal penalties for adults (18 and over) for the possession of up to 3 grams of cannabis and the cultivation of up to 4 plants in a private residence.

By global legalization standards, Luxembourg’s legalization model is clearly limited. Probably the best comparator out there is when the State of Vermont passed a legalization measure in the United States back in 2018.

Vermont, which was the first U.S. state to legalize cannabis via legislative action versus citizen initiative, initially only legalized the possession of up to one ounce of cannabis and the cultivation of up to two plants back in 2018. Commercial sales were still prohibited, although the law would eventually change to permit adult-use sales.

Compared to Uruguay and Canada, which both permit national adult-use sales and considerably greater possession limits, Luxembourg’s new law seems tame. The same is true when comparing Luxembourg’s model to Malta’s model. Malta previously held the time of the most-limited national legalization model with a possession limit of 7 grams and four plants, although Malta’s model at least provides for non-commercial cannabis clubs.

The big metaphorical elephant in the European continent cannabis policy room is, of course, Germany, where a legalization measure has worked its way through the process over the course of the last two years. A measure is expected to officially be submitted to the cabinet for consideration by mid-August.

Compared to what Luxembourg just passed, Germany’s legalization model as currently proposed would be considerably more robust being that it permits cannabis clubs. Below are some of the provisions being considered in Germany pertaining to cannabis clubs:

  • All club properties where cannabis is cultivated and/or stored have to be tightly secured
  • Every club has to have a ‘trained addiction and prevention officer’
  • Must comply with residue limits for pesticides and fertilizers
  • Must track cannabis from seed
  • Annual reporting of crop amounts, including cannabinoid percentage (THC and CBD)
  • Club members only
  • 50 grams per month limit for over 21 years old
  • 30 grams per month limit for 18-20 years old
  • THC percentage cap for 18-20 years old (ten percent THC)
  • Neutral packaging
  • Labeled with specific harvest information

Those provisions are in addition to personal possession (25 grams) and cultivation limits (3 plants), as well as the eventual launch of regional adult-use cannabis commerce pilot programs.

Luxembourg’s new law is definitely better for personal consumers compared to outright prohibition but with such a low possession limit and no legal way to obtain cannabis beyond gifting or personal cultivation, problems are all but guaranteed to arise.

Under the new law, buying and possessing more than three grams of cannabis in Luxembourg is punishable by a prison sentence of up to six months. Even a novice cannabis cultivator can yield harvests that are far more than 3 grams per plant. At a four-plant cultivation limit, a 3-gram possession limit seems completely illogical.

Hopefully, now that some of the stigma has subsided, Luxembourg will work to improve its law, especially considering that legalization is looming large across the border with Germany. Luxembourg needs to do much better than the current law, otherwise, the nation will see just how large of an economic opportunity cost there really is once Germany legalizes and at the possible expense of some of its own citizens’ freedom.

bundestag berlin germany bundestag berlin germany

German Cannabis Legalization Bill Expected To Be In Cabinet By August

Written by Hazel Norman on . Posted in Policy.

As Germany continues its high-profile quest to become the largest nation so far to pass a comprehensive, nationwide adult-use legalization bill, it is being reported that there is finally an estimated cabinet time-of-arrival for such a measure. A legalization measure is expected to be officially submitted to Germany’s cabinet by mid-August.

The announcement of an ETA for the measure comes after roughly two years of lawmakers in Germany haggling and negotiating over what the measure should include, with much of the discussion occurring behind closed doors.

The European Union’s mandatory inclusion in domestic German cannabis policy discussions increased the number of hurdles involved, and with it, increased the duration of the legalization process. However, the light at the end of the tunnel appears to be growing brighter.

At this point, it seems like a lifetime ago when the current governing coalition was elected in Germany back in the summer of 2021, mere weeks after a historic cannabis policy discussion was held at the International Cannabis Business Conference in Berlin.

At the 2021 conference in Berlin, German lawmakers discussed their intent to legalize cannabis in detail if/when the election results were favorable. As we now know, the election results did indeed prove to be favorable for legalization.

The next major milestone came in October 2022 when Germany’s Health Minister Karl Lauterbach presented his initial plan for German legalization, a plan that would later evolve after a series of meetings and discussions between the European Union and Minister Lauterbach.

The evolved plan would eventually be provided by Minister Lauterbach to German lawmakers earlier this year, and it has worked its way around closed political circles ever since. Although, the following provisions have surfaced:

  • All club properties where cannabis is cultivated and/or stored have to be tightly secured
  • Every club has to have a ‘trained addiction and prevention officer’
  • Must comply with residue limits for pesticides and fertilizers
  • Must track cannabis from seed
  • Annual reporting of crop amounts, including cannabinoid percentage (THC and CBD)
  • Club members only
  • 50 grams per month limit for over 21 years old
  • 30 grams per month limit for 18-20 years old
  • THC percentage cap for 18-20 years old (ten percent THC)
  • Neutral packaging
  • Labeled with specific harvest information

Much of what was leaked and reported on in Germany seems to surround noncommercial cannabis clubs, which will be strictly regulated and purely “cultivation associations.” According to domestic reporting, no cannabis can be consumed “within the clubs and within a radius of 250 meters.”

In addition to club provisions, items pertaining to individuals are also reportedly included in the current draft. Consumption is prohibited “within a radius of 250 meters from schools, daycare centers, playgrounds, youth facilities or sports facilities.” Also, consumption “should also not be permitted in pedestrian zones between 7 a.m. and 8 p.m.”

Consumers will be limited to one club membership at a time and permitted to cultivate up to 3 plants. Pharmacies are not allowed to cultivate or sell adult-use cannabis under the current plan, and medical cannabis “is to be removed from the scope of the Narcotics Act.”

In fact, medical cannabis reportedly has its own separate chapter in the latest draft law, which will hopefully provide a boost in safe access for patients, as well as help streamline cannabis research project approvals.

With all of that being said, until a final measure is officially adopted, nothing is ever a sure thing in Germany, and it is vital that advocates inside and outside of elected circles keep up the pressure to help ensure that laws and regulations are as sensible as possible and that whatever is adopted is seen as being a step in the right direction rather than a final destination.

Fibromyalgia Patients Experience Symptom Improvements, Reduce Prescription Use Following THC Treatment

Written by Frank Schuler on . Posted in Science.

Fibromyalgia is a serious health condition creating problems across the globe. It’s a condition that affects people of all ages. It is estimated that as many as one out of every twenty people on the planet suffers from the condition to some degree.

According to Mayo Clinic, “Fibromyalgia is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood issues.”

Unfortunately, there is currently no known cure for fibromyalgia, however, researchers in Germany have found evidence that THC can be an effective treatment for some patients, and for some, lower their reliance on prescription drugs. Below is more information about it via a news release from NORML:

Burghausen, Germany: Patients with fibromyalgia (FM) respond favorably to the administration of oral THC, according to observational data published in the German medical journal Schmerz.

German researchers assessed the efficacy of oral THC capsules (dronabinol) in 62 patients hospitalized with fibromyalgia.

Compared to untreated patients, those consuming oral THC suffered from fewer bouts of depression and experienced “significant improvements” in their quality of life. Patients taking THC were also far more likely than others to either reduce or discontinue their use of pain medications – a finding that is consistent with numerous other studies of patient populations.

Authors concluded: “The results of the present analysis indicate, similar to other studies, that THC could be a medicinal alternative to the substances previously recommended in various guidelines.”

Their conclusions are consistent with those of prior studies finding that FM patients who begin using cannabis products report greater quality of life and reduce their levels of opioid consumption.

Full text of the study, “Tetrahydrocannabinol in patients with fibromyalgia: A retrospective study of changes in pain, psychometric variables, and analgesic consumption during inpatient and interdisciplinary multimodal pain therapy,” appears in Schmerz. Additional information on cannabis and FM is available from NORML’s publication, Clinical Applications for Cannabis and Cannabinoids.

Berlin International Cannabis Business Conference Registration

International Cannabis Leaders Descend On Berlin

Written by Johnny Green on . Posted in Business, Entertainment, Policy, Science.

Global cannabis leaders are arriving in Berlin this week to attend the International Cannabis Business Conference. The events series’ flagship business-to-business (B2B) event is taking place on June 29th and 30th at the iconic Estrel Berlin Hotel.

In addition to the two-day B2B event, which is the largest of its type on the entire European continent, the International Cannabis Business Conference will also host a Global Investment Forum on June 27th at the Hotel Adlon Kempinski Berlin.

The International Cannabis Business Conference is the leading cannabis industry event series on the planet, with previous conferences occurring in several countries on multiple continents. The event series is owned and operated by cannabis advocates that believe in celebrating cannabis culture, in addition to providing world-class cannabis industry education and networking opportunities.

“We are extremely excited about this year’s conference in Berlin given how close Germany is to modernizing its cannabis policies. It is going to be extra special for our team to offer world-class cannabis industry and policy education, networking, and entertainment to attendees at such a historic time for Europe’s emerging cannabis industry,” says Alex Rogers, founder of the International Cannabis Business Conference.

It is becoming increasingly difficult to gain an edge on the competition in the emerging international cannabis industry, and it’s vital for people to get their idea, product, or service in front of the right people at the right time. With executives, entrepreneurs, investors, policymakers, and industry service providers converging from across the planet in Berlin this week, the B2B trade show event in Berlin is the perfect place for people to put their cannabis ideas on the global cannabis stage. Click here for a full list of B2B conference speakers.

Not all networking opportunities are created equal, and that is particularly true in the cannabis space. International Cannabis Business Conference events are attended by cannabis leaders from dozens of different countries, with the Berlin B2B event serving as the top international cannabis event of its type for 2023. Click here for the event’s full schedule and curriculum.

Cannabis industry opportunities that are popping up in Germany and on the European continent have tremendous profit potential, and the Global Investment Forum is the perfect place for entrepreneurs to try to secure capital to take their pursuits to the next level. It is also an unparalleled opportunity for investors to learn more about pre-vetted investment opportunities and for industry service providers to find reliable and high-end clients.

“We know how hard it is for quality investors to link up with vetted cannabis industry companies offering valuable investment opportunities,” Rogers stated. “That is why we are bringing the Global Investment Forum back to Berlin. It will be a prime networking opportunity for cannabis industry investors, entrepreneurs, and industry service providers alike.”

Sixty-one percent of polled Germans support the controlled sale of adult-use cannabis in licensed stores. It is estimated that legalizing cannabis sales for adult use in Germany would quickly create 27,000 new jobs. Additionally, Germany’s current legalization plan includes removing cannabis from the country’s narcotics law, which will have a significant impact on all sectors of the nation’s emerging cannabis industry.

Thousands of cannabis leaders from dozens of countries will be represented at the International Cannabis Business Conference in Berlin and that includes representatives from every sector of the industry as well as leading international cannabis policymakers and industry service providers. Attend the International Cannabis Business Conference in Berlin to take your industry pursuits to the next level.

A limited number of tickets are currently available. Secure your tickets now before the events sell out!

purple cannabis plant flower bud

What Is Next For The Cannabis Industry?

Written by Hazel Norman on . Posted in Business, Policy.

The emerging legal cannabis industry is continuing to undergo a dramatic evolution, particularly in Europe. The momentum for global reform is greater now than at any other time since the dawn of prohibition, and the biggest domino to date is teetering and getting closer to toppling with every passing day. That domino is, of course, Germany.

Cannabis advocates have fought for reform in Germany for many years, however, the legalization effort picked up considerable steam in mid-2021 when the results of the federal election that year yielded a governing coalition that quickly expressed its desire to modernize Europe’s cannabis policies.

Germany was already home to the largest legal medical cannabis industry in Europe at the time, and initially, it seemed that Germany would launch legal national adult-use cannabis sales in a quick fashion. Then, for over a year, German Health Minister Karl Lauterbach worked behind the scenes, with details of his legalization plan leaking every once in a while.

Eventually, Minister Lauterbach held a press conference in October 2022 to announce some of the provisions he would be seeking but made it abundantly clear that his next stop was the European Union to try to get its permission to proceed.

Unfortunately, the effort hit some turbulence once Germany’s Health Minister started negotiating with the European Union, with Minister Lauterbach providing an update in April 2023 in which he indicated that the European Union would allow parts of the previously outlined legalization plan to proceed and prohibit other parts.

The main component that the European Union stated it would not permit was nationwide adult-use cannabis sales to anyone of legal age. The blocking of that robust provision seemed to send many newer industry members into a bit of a spiral. The fact of the matter is that cannabis reform rarely, if ever, follows a linear path. It is full of twists and turns, and Germany is the latest example of that.

With those twists and turns comes opportunity, as not everyone is able to navigate the shifting landscape. People who are able to navigate the shifting landscape, that can identify trends, and maximize windows of opportunity, will reap significant rewards.

What legalization will ultimately look like in Germany once it is finally implemented is something that we will have to wait and see, however, the basic provisions are already known – personal cultivation, possession, and consumption will be legal and noncommercial clubs will be permitted.

Eventually, regional adult-use commerce pilot programs will launch as well. All of that creates opportunities for entrepreneurs, investors, and industry service providers if they know what to anticipate and where to focus on developing innovative ideas.

The best way to learn what is next for the emerging cannabis industry, both in Germany and beyond, is to hear from true international cannabis experts that spend every day on the frontlines of cannabis reform and industry. Fortunately, the upcoming International Cannabis Business Conference in Berlin, Germany later this month provides that exact opportunity.

Following yet another successful cannabis super-event in Barcelona, the International Cannabis Business Conference is once again bringing its flagship B2B event and tradeshow back to Berlin, Germany on June 29th-30th, 2023. In addition to the B2B event, which is the largest of its type in Europe, the International Cannabis Business Conference will also hold a Global Investment Forum in Berlin on June 27th.

Both events will feature leading cannabis industry experts, and the B2B event has a panel specifically dedicated to discussing what is next for the international cannabis industry now that the curtain dropped in Germany. The panel will feature:

Over 5,000 cannabis leaders from over 80 countries will be represented at the International Cannabis Business Conference in Berlin and that includes representatives from every sector of the industry as well as leading international cannabis policymakers and industry service providers.

Attend the International Cannabis Business Conference in Berlin to network with investors, entrepreneurs, industry regulators, and international policymakers and take your industry pursuits to the next level. Secure your tickets now before the event sells out!

Czech Republic Germany Cannabis

Czech Health Minister: ‘We Are Waiting For Germany To Legalize Cannabis’

Written by Johnny Green on . Posted in Policy.

One of the most active places on the planet right now for cannabis reform discussions is the Czech Republic. If you have followed our previous coverage, then you know that there is a strong push underway in the Czech Republic to legalize cannabis for adult use.

In October 2022 the national anti-drug coordinator for the Czech Republic, Jindřich Vobořil, announced his plan to pursue adult-use legalization.

“At the moment, there is a political consensus for me to create this proposal for the regulation of cannabis, a substance which is illegal at the moment. We want to regulate it with the help of the market and we believe that this regulation will be more effective than the current ban.” Jindřich Vobořil stated at the time.

Mere days after Germany’s Health Minister Karl Lauterbach held a historic press conference in Germany to provide an update about his nation’s legalization plans, news broke in the Czech Republic about some of the facets that may eventually make it into Czech law.

The model that made headlines back then (April 2023) involves the Czech Republic legalizing adult-use cannabis production and sales under a tightly regulated system. Consumers would be able to purchase up to five grams of cannabis per day according to domestic reporting, and consumers would be required to sign up through a government tracking database.

Meanwhile, running parallel to the reform push was the prosecution in the Czech Republic of a cannabis educator and journalist named Robert Veverka. Robert Veverka is the director of the Czech-based cannabis magazine Legalizace. Back in October 2021, we published an article about Robert being targeted by the Czech government over his journalism, with the government accusing him of “inciting and promoting toxicomania.”

Unfortunately, the Czech Republic proceeded with the indictment and in November 2021 Veverka and his media outlet were found guilty of the allegations, and Veverka was given a one-year prison sentence contingent on a probationary period of two and a half years as well as a fine of 50,000 CZK by the district court in Bruntál following two court hearings.

“The judge mentioned that he is not competent to assess the benefits of the current legislation, the benefits of cannabis products in healthcare, or the negative effects of cannabis use, but that he must base his verdict on the existing legislation which is binding for all. He stated that according to his judgement, Legalizace magazine evidently and factually constituted the criminal offence of inciting and promoting toxicomania.” Veverka stated at the time of the November 2021 verdict in a press release.

“He did not take into account the legislative provisions allowing for cannabis to be handled legally in certain cases or the comprehensive and educational nature of the information published in the magazine. On the contrary, the judge expressed his doubts as to whether the individuals who granted interviews to the magazine were made aware of its content and overall message. Personally, I consider the verdict to be very biased and severely restrictive of the freedom of expression, the right to express political opinion, and the right to information,” Veverka also stated.

Veverka must reportedly pay an administrative offense of €4.000 (as a defendant and a natural person) and €6.000 on behalf of his media outlet as part of an additional recent verdict. For anyone that is able to support Robert Veverka and contribute to his defense, bank details are below. If you are not able to contribute financially, please help spread the word on your social channels about his plight:

IBAN: CZ4320100000002900469065
BIC/SWIFT: FIOBCZPPXXX
Fio banka, as, V Celnici 1028/10, 117 21 Praha 1

This month the cannabis reform discussion in the Czech Republic took yet another turn, with the nation’s health minister offering up a series of comments about the nation’s push to legalize cannabis for adult use.

Minister Vlastimil Válek’s comments seemed to fail to accurately describe where things are currently at in Germany regarding cannabis reform, particularly as it pertained to Germany’s discussions with the European Union. Per ZdraveZpravy.cz:

Nevertheless, Minister Válek expressed his opinion regarding the actual approval of the standard, which would open up the market for cannabis containing a high amount of the psychoactive substance THC from January next year. He said that he is waiting for his colleagues from Germany, who are also trying to take a similar step. However, they are worried about how the European Commission [EC] and other EU member states, which oppose cannabis, would accept the legalization of cannabis in Germany. At stake are impacts on the EU-wide legal and illegal cannabis trade and market. It is exactly this, along with other questions, that the Germans are dealing with with EC representatives.

“I’m waiting for colleagues from Germany who are trying something similar. And they are not at the stage yet, and they promised us that they will show us the draft of the law, which of course the EC must give a positive opinion on, because it will be a certain breakthrough in what is in Europe,” Minister Válek explained to ZdraveZpravy.cz.

For starters, Minister Válek’s comments seem to passively disregard the fact that Malta has already passed an adult-use legalization measure and that regional adult-use cannabis commerce pilot programs also are already in existence in Europe (albeit in a limited-scope fashion).

To be fair, legalization in Germany would presumably be performed on a much larger scale than what is going on in Malta and with pilot programs in places such as Basel, Switzerland. However, the basic principle of the European Union and member states dealing with modernized cannabis policies in some form in some nations is not a new thing. The ‘what will Europe do if laws are reformed?’ talking point died a while ago, and it’s obviously time for cannabis opponents to move on.

German Health Minister Lauterbach made it clear in his April 2023 press conference that while the European Union would not permit nationwide sales to anyone of legal age, many of the components of Minister Lauterbach’s legalization did appear to receive approval, or at least that the European Union would not stand in the way of them.

While there is nearly no way to know if Minister Lauterbach has personally sent a copy of the current version of Germany’s legalization plan to his counterpart in the Czech Republic, there is still a considerable amount of information out in the public regarding where things currently stand and what is involved, and that the legalization plan is currently working its way around political circles in Germany.

For Minister Válek to act so clueless about where things are at in Germany seems disingenuous to me, however, that is not uncommon in politics. Ultimately, as things move along in Germany the pressure will build in the Czech Republic and many other parts of Europe, and many of the talking points that are being thrown around right now will fizzle.

planet earth

The Global Rise Of Medical Cannabis

Written by Johnny Green on . Posted in Business, Science.

The legal medical cannabis industry is a global powerhouse now, however, that was obviously not always the case. International economists estimate that the legal medical cannabis market topped $31.8 billion USD in 2022 and that by 2030 the market size could more than double.

Yet, the emerging legal medical cannabis industry comes from fairly humble beginnings going back to the mid-1990s in California. A coalition of dedicated activists succeeded in getting the first medical cannabis legalization measure passed in California in 1996 and that victory set off a chain reaction that is still sweeping the globe today.

As medical cannabis reform has spread across the planet over the better part of the last three decades, the industry itself has evolved considerably during the same time period. The young legal industry in California in the mid-1990s doesn’t resemble the medical cannabis industry in existence today, including within California’s own borders.

The modern medical cannabis industry is far more sophisticated now compared to decades past, and rules and regulations are far more complex. With the rise of legal medical cannabis imports and exports, the complexities will likely only increase going forward.

Furthermore, adult-use reform is on the move, particularly in Europe where Germany is on the cusp of passing a national adult-use legalization measure. The modernization of adult-use cannabis policies will no doubt have an impact on medical cannabis policies in the regions where adult-use reform occurs.

All of that can make it hard to get a grasp on trends and opportunities, and it’s even harder when the industry and policy landscape shifts, which seems to be a frequent thing these days. Fortunately, there’s an opportunity to learn directly from leading international cannabis experts at the upcoming International Cannabis Business Conference in Berlin on June 29th-30th.

One of the panels for the conference, which is the largest and longest-running event of its type in Europe, is dedicated to discussing the rise of the global medical cannabis industry, and what impact legalization in Germany will have on the sector.

Georgia Glick, Head of Partnerships for Hanway Associates, will serve as the moderator of ‘The Global Rise of Medical Cannabis’ panel in Berlin. Joining Georgia Glick will be Lily Temperton, Head of Analysis for Hanway Associates, Lisa Haag, Founder of MJ_Universe, Alex Revich, Equity Partner at Hybrid Pharm and Cannabis Education & Medical Partnerships at Loosh Brands, Fleta Solomon, CEO of Little Green Pharma, and Dr. Malgorzata Meunier, CSO of Hapa Pharm.

Germany has emerged as a key player in the global medical cannabis market, with a robust regulatory framework and a growing number of patients accessing cannabis for therapeutic use. Although, Germany is not alone in its pursuit of medical cannabis.

Around the world, countries are exploring the potential of cannabis to treat a range of conditions, from chronic pain to epilepsy to cancer. In this panel, experts from Germany and beyond will take a closer look at the role of Germany in the international medical cannabis industry and explore emerging markets and pilot programs around the planet.

The panel will also discuss the critical importance of education for healthcare professionals, patients, and policymakers to ensure the safe and effective use of medical cannabis. You can view the full schedule for the upcoming International Cannabis Business Conference in Berlin at this link here.

Over 5,000 cannabis leaders from over 80 countries will be represented at the International Cannabis Business Conference in Berlin and that includes representatives from every sector of the industry as well as leading international cannabis policymakers and industry service providers.

Attend the International Cannabis Business Conference in Berlin to network with investors, entrepreneurs, industry regulators, and international policymakers and take your industry pursuits to the next level. Secure tickets now before the event is sold out!